Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Here's How Much $1000 Invested In Tesla 10 Years Ago Would Be Worth Today

Tesla (NASDAQ:TSLA) has outperformed the market over the past 10 years by 48.14% on an annualized basis producing an average annual return of 58.9%. Currently, Tesla has a market capitalization of $683.52 billion.

$1000 Invested In T-Mobile US 5 Years Ago Would Be Worth This Much Today

$1000 Invested In T-Mobile US 5 Years Ago Would Be Worth This Much Today

T-Mobile US (NASDAQ:TMUS) has outperformed the market over the past 5 years by 6.27% on an annualized basis producing an average annual return of 14.94%. Currently, T-Mobile US has a market capitalization of $160.94 billion.

How Is The Market Feeling About Lululemon Athletica?

How Is The Market Feeling About Lululemon Athletica?

Lululemon Athletica's (NASDAQ:LULU) short percent of float has fallen 5.64% since its last report. The company recently reported that it has 2.79 million shares sold short, which is 2.51% of all regular shares that are available for trading.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

HTG Molecular Diagnostics's Return On Capital Employed Insights

HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $1.18 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 25.16%, resulting in a loss of $6.50 million.

NeuroPace Earnings Perspective: Return On Capital Employed

Benzinga Pro data, NeuroPace (NASDAQ:NPCE) reported Q1 sales of $11.37 million. Earnings fell to a loss of $11.46 million, resulting in a 7.18% decrease from last quarter.

Acutus Medical's Return On Capital Employed Overview

Benzinga Pro data, Acutus Medical (NASDAQ:AFIB) reported Q1 sales of $3.68 million. Earnings fell to a loss of $40.02 million, resulting in a 28.0% decrease from last quarter.

CASI Pharmaceuticals's Return On Capital Employed Insights

Benzinga Pro data, CASI Pharmaceuticals (NASDAQ:CASI) reported Q1 sales of $9.06 million. Earnings fell to a loss of $8.40 million, resulting in a 55.7% decrease from last quarter.

inkl

Read news from The Economist, FT, and more,
with one subscription

Aptevo Therapeutics's Return On Capital Employed Overview

Aptevo Therapeutics's Return On Capital Employed Overview

Benzinga Pro data, Aptevo Therapeutics (NASDAQ:APVO) reported Q1 sales of $3.11 million. Earnings fell to a loss of $7.70 million, resulting in a 22.72% decrease from last quarter.

Cyxtera Technologies Earnings Perspective: Return On Capital Employed

Cyxtera Technologies Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q1, Cyxtera Technologies (NASDAQ:CYXT) posted sales of $182.40 million. Earnings were up 37.65%, but Cyxtera Technologies still reported an overall loss of $40.90 million.

Dynatronics's Return On Capital Employed Insights

Dynatronics's Return On Capital Employed Insights

Dynatronics (NASDAQ:DYNT) brought in sales totaling $10.32 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 2.1%, resulting in a loss of $1.47 million.

4 Analysts Have This to Say About Intapp

4 Analysts Have This to Say About Intapp

Intapp (NASDAQ:INTA) has observed the following analyst ratings within the last quarter:

Benchmark Bullish On Hub Group, Sees 30% Upside

Benchmark Bullish On Hub Group, Sees 30% Upside

Benchmark analyst Christopher Kuhn initiated coverage of Hub Group Inc (NASDAQ:HUBG) with a Buy rating and a price target of $90, implying an upside of 31%. According to the analyst, intermodal volume growth will turn positive in 2022. Kuhn anticipates growth to continue in 2022, but he sees margins normalizing in 2023 as pricing…

4 Analysts Have This to Say About Centessa Pharmaceuticals

4 Analysts Have This to Say About Centessa Pharmaceuticals

Analysts have provided the following ratings for Centessa Pharmaceuticals (NASDAQ:CNTA) within the last quarter:

Where Urban Outfitters Stands With Analysts

Where Urban Outfitters Stands With Analysts

Within the last quarter, Urban Outfitters (NASDAQ:URBN) has observed the following analyst ratings:

Get all your
news in one place.

100's of premium titles.
One news app.

What To Watch For On Advanced Micro Devices Stock As It Continues In This Trend

Advanced Micro Devices, Inc. (NASDAQ: AMD) plunged more than 8% on Thursday and was trading slightly higher when the markets opened on Friday.

VYNE Therapeutics Concludes Patient Enrolment in Mid-Stage Study Of Skin Inflammation Candidate

VYNE Therapeutics Inc. (NASDAQ: VYNE) has concluded patient enrollment in the Phase 2a study of of its drug candidate FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD).

Final Draft Of Macau Gaming Law: What Investors Need To Know

The Macau Legislative Assembly signed the final draft of the new Macau gaming law this week. Bank of America analyst Billy Ng says there's nothing in the legislation that dampens his long-term bullish thesis on the Macau gaming market. Draft Updates: The final draft of the law includes the following…

Why Shares Of Addex Therapeutics Are Falling Today

Shares of small-cap penny stock Addex Therapeutics Ltd. (NASDAQ: ADXN) are trading lower after the company terminated its Phase 2b/3 study of Dipraglurant for dyskinesia associated with Parkinson's disease due to slow recruitment. The company suspended its guidance amid the termination.

Get all your
news in one place.

100's of premium titles.
One news app.

Why Mereo BioPharma Shares Are Jumping Today

AstraZeneca plc (NASDAQ:AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ:MREO), according to a report in The Times. The Times' report says that "Mereo would accept $5, equating to $500 million including American depositary receipts or ADRs. Evercore and Citigroup are said to be involved as advisers." Mereo's lead…

Allegiant Travel Clocks ~17% Growth In May Capacity

Allegiant Travel Company (NASDAQ:ALGT) May 2022 Scheduled Service capacity grew by ~16% and completed the month with a load factor of 87%, up 3.0pts, compared to 2019 numbers. "The average cost per fuel gallon in May was $4.41 and we now expect to finish the quarter at an average cost per gallon…

Why Shares Of ToughBuilt Industries Are Tanking Today

Shares of small-cap penny stock ToughBuilt Industries, Inc. (NASDAQ: TBLT) are trading lower after the company priced a $6 million offering.

U.S. Markets Open Higher; Dow Rises Around 200 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Friday.

Monro Completes Sale Of Tires Now Assets To American Tire Distributors

Monro Inc (NASDAQ:MNRO) has completed the previously-announced sale of its wholesale tire and distribution assets to American Tire Distributors (ATD). The company sold its Tires Now distribution assets for $105 million in cash. Monro's wholesale tire locations included seven facilities in Kentucky, North Carolina, South Carolina, and Tennessee which serviced more than 3,500 wholesale customer…

TikTok President Reasons Why Copying The Former Will Not Be Conducive For Facebook

TikTok's President of Global Business Solutions and former Meta Platforms, Inc (NASDAQ:META) Facebook veteran Blake Chandlee in a CNBC interview, shared how TikTok massively differed from Facebook. ByteDance Ltd-owned TikTok did not look to mimic Facebook. In contrast, Facebook struggled to win users by restructuring its Facebook and Instagram apps to emulate TikTok's popular short video format.…

Jim Cramer Recommends Buying This Stock

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Terran Orbital Corp (NASDAQ: LLAP) is one of those "newer companies that doesn’t have any earnings."

1 … 400 401 402 403

People

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bank of America

Urban Outfitters

AstraZeneca Plc

Lululemon Athletica

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Social Networking

Places

375,095 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play